Correlation between albuminuria and interstitial injury marker reductions associated with SGLT2 inhibitor treatment in diabetic patients with renal dysfunction
Abstract Background We investigated the effects of sodium–glucose cotransporter 2 inhibitor (SGLT2i) administration focusing on its involvement in tubulo-interstitial disorders in diabetic kidney. Methods Enrolled patients with diabetic kidney disease received a mean dose of 52.3 mg of an SGLT2i (ip...
Main Authors: | Saeko Sato, Kaori Takayanagi, Taisuke Shimizu, Koichi Kanozawa, Takatsugu Iwashita, Hajime Hasegawa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | European Journal of Medical Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40001-022-00737-5 |
Similar Items
-
Urinary N-Acetyl-β-D glucosaminidase (uNAG) levels as an early marker for diabetic nephropathy in children with type 1 diabetes
by: Emad E. Ghobrial, et al.
Published: (2022-12-01) -
Urinary N-Acetyl-β-d-Glucosaminidase (NAG) Levels and Risk of Cardiovascular Events in Diabetic Patients
by: Lou W, et al.
Published: (2021-12-01) -
High Glycated Hemoglobin Instead of High Body Mass Index Might Increase the Urine <i>N</i>-Acetyl-β-D-glucosaminidase Con-Centration in Children and Adolescents with Diabetes Mellitus
by: Jin-Soon Suh, et al.
Published: (2022-06-01) -
Activities of N-acetyl-β-d-glucosaminidase and glutathione peroxidase in bovine colostrum and milk
by: M. Kankofer, et al.
Published: (2010-11-01) -
Hafif preeklampside üriner N-asetil-β-D-glukozaminidaz (NAG) ve renal tübüler hasar
by: Mustafa ULUBAY, et al.
Published: (2017-06-01)